FDA Authorizes Pharmacists to Prescribe Paxlovid
The FDA has granted state-licensed pharmacists the power to prescribe Paxlovid (nirmatrelvir and ritonavir) to eligible patients, with certain limitations.
The FDA has granted state-licensed pharmacists the power to prescribe Paxlovid (nirmatrelvir and ritonavir) to eligible patients, with certain limitations.
Vitalograph is celebrating 21 years of empowering respiratory research through clinical trials services, with international team members fundraising for local respiratory charities to mark the milestone.
The American Lung Association millennial lung study will track 4,000 young adults (aged 25-35) at the age of peak lung health for five years to evaluate how their environment, lifestyle, and physical activity habits affect respiratory health.
A 10-µg dose (third dose) of the Pfizer pediatric booster in healthy children age 5 through 11...
A clinical trial by the NIAID will study rare but potentially serious systemic allergic reactions to COVID vaccines.
An expanded ACTIV-6 study will test 600 mcg/kg of ivermectin daily for six days in patients who have had a positive COVID-19 test within the past 10 days, and have at least two symptoms of the illness for no more than seven days.